Waters trades at a P/E of 46.8—nearly double the technology sector median—despite RSI of 46.6 suggesting the stock isn't technically overbought. The $31.4B market cap reflects a company priced for sustained high-growth execution in analytical instrumentation, yet valuation doesn't align with typical laboratory equipment cyclicality or competitive pressures. At prices below the 52-week high, there's disconnect between the stretched multiple and recent momentum weakness. This suggests the market is either heavily discounting future earnings acceleration or pricing in significant execution risk that current fundamentals haven't fully reflected.
Snapshot
Recent headlines
Peers in Laboratory Analytical Instruments
Build a thesis around WAT
Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.
Open in AlgoThesis →